Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

VEGFC anticorps (AA 321-415)

L’anticorps Lapin Polyclonal anti-VEGFC a été validé pour WB, ELISA, FACS, IHC (p), IF (cc), IF (p) et IHC (fro). Il convient pour détecter VEGFC dans des échantillons de Humain, Souris et Rat. Il y a 3+ publications disponibles.
N° du produit ABIN731723

Aperçu rapide pour VEGFC anticorps (AA 321-415) (ABIN731723)

Antigène

Voir toutes VEGFC Anticorps
VEGFC (Vascular Endothelial Growth Factor C (VEGFC))

Reactivité

  • 102
  • 60
  • 43
  • 5
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Humain, Souris, Rat

Hôte

  • 100
  • 41
  • 3
  • 1
  • 1
  • 1
Lapin

Clonalité

  • 107
  • 40
Polyclonal

Conjugué

  • 66
  • 20
  • 15
  • 7
  • 6
  • 5
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp VEGFC est non-conjugé

Application

  • 128
  • 55
  • 55
  • 26
  • 25
  • 25
  • 22
  • 22
  • 11
  • 7
  • 7
  • 5
  • 3
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
  • Épitope

    • 20
    • 15
    • 15
    • 8
    • 6
    • 5
    • 5
    • 4
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 321-415

     Réactivité croisée

    Humain, Souris, Rat

    Purification

    Purified by Protein A.

    Immunogène

    KLH conjugated synthetic peptide derived from mouse VEGF-C

    Isotype

    IgG
  • Indications d'application

    WB 1:300-5000
    ELISA 1:500-1000
    FCM 1:20-100
    IHC-P 1:200-400
    IHC-F 1:100-500
    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 μg/μL

    Buffer

    0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

    Date de péremption

    12 months
  • Alunno, Ibba-Manneschi, Bistoni, Rosa, Caterbi, Gerli, Manetti: "Mobilization of lymphatic endothelial precursor cells and lymphatic neovascularization in primary Sjögren's syndrome." dans: Journal of cellular and molecular medicine, Vol. 20, Issue 4, pp. 613-22, (2016) (PubMed).

    He, Qi, Jia, Wang, Wang, Song, Fu, Li, Luo: "Tumor cell-secreted angiogenin induces angiogenic activity of endothelial cells by suppressing miR-542-3p." dans: Cancer letters, Vol. 368, Issue 1, pp. 115-25, (2015) (PubMed).

    Zhuo, Jia, Song, Lu, Ding, Wang, Song, Fu, Luo: "The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis." dans: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 18, Issue 19, pp. 5387-98, (2012) (PubMed).

  • Antigène

    VEGFC (Vascular Endothelial Growth Factor C (VEGFC))

    Autre désignation

    VEGF-C

    Sujet

    Synonyms: VEGF-C, AW228853, Vascular endothelial growth factor C, Flt4 ligand, Flt4-L, Vascular endothelial growth factor-related protein, VRP, Vegfc

    Background: Growth factor active in angiogenesis, and endothelial cell growth, stimulating their proliferation and migration and also has effects on the permeability of blood vessels. May function in angiogenesis of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. Binds and activates VEGFR-2 (KDR/FLK1) and VEGFR-3 (FLT4) receptors.

    ID gène

    22341

    UniProt

    P97953

    Pathways

    Signalisation RTK, Signaling Events mediated by VEGFR1 and VEGFR2
Vous êtes ici:
Chat with us!